Skip to content
Screener

Xencor XNCR Advance Future Royalty And Milestone Payments

Advance Future Royalty And Milestone Payments at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$12.81M-44.3%
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$8M
U.S. Gold Corp. logo
U.S. Gold Corp.USAU
$125K-16.7%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$20M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$77M0.0%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$9.2M

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.47B+176%
Enterprise value$1.6B+128%
P/S14×+10.4×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept xncr:AdvanceFutureRoyaltyAndMilestonePayments.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Cash flows from financing activities
Proceeds from the exercises of stock options9852,974
Proceeds from issuance of common stock under the Employee Stock Purchase Plan996662
Cash paid to acquire noncontrolling interest(1,725)
Net cash provided by financing activities1,9811,911
Net (decrease) increase in cash, cash equivalents, and restricted cash(9,508)3,466
Cash, cash equivalents, and restricted cash, beginning of period54,36241,262
Cash, cash equivalents, and restricted cash, end of period$44,854$44,728

Item 1. Financial Statements

FAQ

What is Xencor's advance future royalty and milestone payments?
Xencor (XNCR) reported advance future royalty and milestone payments of $0 in Q2 2026.
What does advance future royalty and milestone payments mean?
Advance Future Royalty And Milestone Payments as reported by Xencor, Inc..

Ask your AI about Xencor's advance future royalty and milestone payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude